Related Experiment Video
Updated: Dec 25, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Interactions between Avibactam and Ceftazidime-Hydrolyzing Class D β-Lactamases
Jean-Marie Frère1, Pierre Bogaerts2, Te-Din Huang2
1Centre for Protein Engineering, University of Liège, B 4000 Liège, Belgium.
Abstract:
Class D β-lactamases exhibit very heterogeneous hydrolysis activity spectra against the various types of clinically useful β-lactams. Similarly, and according to the available data, their sensitivities to inactivation by avibactam can vary by a factor of more than 100. In this paper, we performed a detailed kinetic study of the interactions between two ceftazidime-hydrolyzing OXA enzymes and showed that they were significantly more susceptible to avibactam than several other class D enzymes that do not hydrolyze ceftazidime. From a clinical point of view, this result is rather interesting if one considers that avibactam is often administered in combination with ceftazidime.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Antimicrobial Effectiveness
Pharmacokinetics: Drug–Drug Interactions
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

